Renping Zhou Selected Research

Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)

1/2019

Inhibition of EphA/Ephrin-A signaling using genetic and pharmacologic approaches improves recovery following traumatic brain injury in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Renping Zhou Research Topics

Disease

3	Neoplasms (Cancer) 01/2021 - 07/2010
3	Carcinogenesis 08/2019 - 09/2008
3	Cataract (Cataracts) 01/2016 - 10/2008
2	COVID-19 01/2021 - 01/2021
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 01/2020
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2019 - 02/2002
2	Pathologic Processes 11/2010 - 09/2008
1	Myeloid Leukemia (Leukemia, Myelocytic) 10/2020
1	Edema (Dropsy) 08/2019
1	Inflammation (Inflammations) 08/2019
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2019
1	Demyelinating Diseases (Demyelinating Disease) 01/2017
1	Hemorrhage 02/2016
1	Infertility (Sterility) 02/2016
1	Persistent Hyperplastic Primary Vitreous 03/2014
1	Neurodevelopmental Disorders 01/2013
1	Adenocarcinoma 07/2010
1	Colonic Neoplasms (Colon Cancer) 07/2010
1	Aberrant Crypt Foci 07/2010
1	Body Weight (Weight, Body) 04/2008
1	Neuritis (Polyneuritis) 02/2007
1	Colorectal Neoplasms (Colorectal Cancer) 02/2007
1	Brain Injuries (Brain Injury) 03/2006
1	Ischemia 03/2006
1	Hepatocellular Carcinoma (Hepatoma) 11/2003

Drug/Important Bio-Agent (IBA)

8	EphrinsIBA 01/2019 - 11/2003
5	Ephrin-A5 (AL-1)IBA 02/2016 - 10/2008
5	LigandsIBA 01/2016 - 11/2003
2	Chimeric Antigen ReceptorsIBA 01/2021 - 01/2021
2	Monoclonal AntibodiesIBA 01/2021 - 01/2021
2	AnticoagulantsIBA 01/2021 - 01/2021
2	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2021
2	VaccinesIBA 01/2021 - 01/2021
2	Immunologic Factors (Immunomodulators)IBA 01/2021 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 03/2006
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2008 - 11/2003
1	Ditiocarb (Sodium Diethyldithiocarbamate)FDA Link 10/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	Celecoxib (Celebrex)FDA Link 01/2020
1	CurcuminIBA 01/2020
1	farnesylthiosalicylic acidIBA 01/2020
1	Gemcitabine FDA Link 01/2020
1	CytokinesIBA 08/2019
1	TriterpenesIBA 08/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2019
1	Matrix Metalloproteinases (MMPs)IBA 08/2019
1	Protein Tyrosine PhosphatasesIBA 01/2019
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 01/2019
1	Glial Fibrillary Acidic ProteinIBA 01/2019
1	DAPIIBA 01/2019
1	Phosphates (Orthophosphate)IBA 01/2019
1	CuprizoneIBA 01/2017
1	FibrinIBA 02/2016
1	Phosphotransferases (Kinase)IBA 01/2016
1	Capsules (Microcapsules)IBA 01/2016
1	tyrosine receptor (receptor, tyrosine)IBA 01/2016
1	EphA1 Receptor (Eph Receptor)IBA 01/2013
1	Biological ProductsIBA 11/2010
1	Eph Family Receptors (Eph Receptors)IBA 11/2010
1	beta CateninIBA 07/2010
1	AzoxymethaneIBA 07/2010
1	pterostilbeneIBA 07/2010
1	NF-kappa B (NF-kB)IBA 07/2010
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 07/2010
1	StilbenesIBA 07/2010
1	Cyclin D1IBA 07/2010
1	Serotonin (5 Hydroxytryptamine)IBA 04/2008
1	NetrinsIBA 02/2007
1	Netrin-1IBA 02/2007
1	NeuroglobinIBA 03/2006
1	Biomarkers (Surrogate Marker)IBA 03/2006
1	Erythropoietin FDA Link 11/2003
1	GinsenosidesIBA 02/2002

Therapy/Procedure

2	Immunotherapy 01/2021 - 01/2021
2	Therapeutics 01/2021 - 01/2021
2	Lenses 01/2016 - 01/2013
1	Drug Therapy (Chemotherapy) 01/2020